MediWaste
closedOn-site pharmaceutical and medical waste treatment systems
Deal Size
$38M
Stage
Series B
Sector
Medical Waste Treatment
Location
Minneapolis, MN
Deal Overview
MediWaste builds compact, automated treatment systems that destroy pharmaceutical compounds, chemotherapy agents, and other regulated medical waste on-site at hospitals and pharmacies. Current practice ships medical waste to distant incineration facilities—expensive, carbon-intensive, and creating chain-of-custody liability. MediWaste's systems use advanced oxidation to render waste non-hazardous in under 4 hours, reducing costs by 50% and eliminating transport risk. Installed at 120+ healthcare facilities across 22 states.
Key Highlights
- ✓Destroys pharma waste on-site in under 4 hours
- ✓50% cost reduction vs offsite incineration
- ✓120+ hospital and pharmacy installations
- ✓$14M ARR with 95% gross retention
Founders
- Dr. Patricia Hwang
- Robert Andersson
Investors
- WasteVC
- Define Ventures
- 8VC
Interested in Similar Deals?
WasteVC invests from Seed to Series B in waste management and circular economy startups.